Target intelligence / Profile preview

Natural cytotoxicity triggering receptor 1 pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

The natural cytotoxicity triggering receptor 1 pseudogene (ENSG00000226570) is a non-functional genomic sequence related to the protein-coding gene NCR1, which encodes NKp46 (CD335), a major receptor on natural killer (NK) cells that mediates cytotoxic activity against tumor and pathogen-infected cells. Being a pseudogene, ENSG00000226570 does not produce a functional protein and has no known therapeutic, biomarker, or drug interaction roles. The true therapeutic target is NCR1 (ENSG00000189430), not the pseudogene. Pseudogenes such as ENSG00000226570 are typically characterized by mutations or deletions that prevent protein production or function, and are not considered valid drug targets or biomarkers. The actual therapeutic and immunological significance comes from the functional gene NCR1 and its protein, NKp46. The true NKp46 (NCR1/CD335/LY94) is a well-validated immunological receptor, involved in NK cell activation and cancer immunotherapy research. ENSG00000226570 is a pseudogene, not a valid therapeutic target. For functional or drug discovery information, users should refer to the protein-coding NCR1 gene instead.

Other names
NCR1 pseudogeneNCR1PENSG00000226570Natural killer cell p46-related protein pseudogene

Beyond the preview

Go deeper on Natural cytotoxicity triggering receptor 1 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural cytotoxicity triggering receptor 1 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call